Evidence map›Paper›PMID 31182472›Full record

ArticleeNeuro

Nociceptor Deletion of Tsc2 Enhances Axon Regeneration by Inducing a Conditioning Injury Response in Dorsal Root Ganglia.

Dan Carlin, Alexandra E Halevi, Eric E Ewan, Amy M Moore, Valeria Cavalli

Open access · goldAbstract read
In one paragraph

Article in eNeuro. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Review
  3. Self-renewing macrophages in dorsal root ganglia contribute to promote nerve regeneration.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Immune Actions on the Peripheral Nervous System in Pain.International journal of molecular sciences · 2021
    Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Dan CarlinDepartment of Neuroscience, Washington University School of Medicine, St. Louis, MO 63110.
Alexandra E HaleviDivision of Plastic and Reconstructive Surgery, Washington University School of Medicine, St. Louis, MO 63110.
Eric E EwanDepartment of Neuroscience, Washington University School of Medicine, St. Louis, MO 63110.
Amy M MooreDivision of Plastic and Reconstructive Surgery, Washington University School of Medicine, St. Louis, MO 63110.
Valeria CavalliDepartment of Neuroscience, Center of Regenerative Medicine, Hope Center for Neurological Disorders, Washington University School of Medicine, St. Louis, MO 63110 cavalli@wustl.edu.
Washington University in St. Louis · US

Funding

TSC2 AND ERK SIGNALING IN MTOR-DEPENDENT REGENERATION AND NEUROPATHIC PAINR01DE022000 · NIDCR · WASHINGTON UNIVERSITY · PI CAVALLI, VALERIA · 2011 to 2015
$2.8M
ELUCIDATING THE ROLE OF NEURONAL MTOR SIGNALING IN SCHWANN CELL DEVELOPMENTR21NS099603 · NINDS · WASHINGTON UNIVERSITY · PI CAVALLI, VALERIA · 2017 to 2018
$419k
NIDCR NIH HHS R01 DE022000NINDS NIH HHS R21 NS099603
6 · The paper itself

Abstract

Neurons of the PNS are able to regenerate injured axons, a process requiring significant cellular resources to establish and maintain long-distance growth. Genetic activation of mTORC1, a potent regulator of cellular metabolism and protein translation, improves axon regeneration of peripheral neurons by an unresolved mechanism. To gain insight into this process, we activated mTORC1 signaling in mouse nociceptors via genetic deletion of its negative regulator Tsc2. Perinatal deletion of Tsc2 in nociceptors enhanced initial axon growth after sciatic nerve crush, however by 3 d post-injury axon elongation rate became similar to controls. mTORC1 inhibition prior to nerve injury was required to suppress the enhanced axon growth. Gene expression analysis in purified nociceptors revealed that Tsc2-deficient nociceptors had increased activity of regeneration-associated transcription factors (RATFs), including cJun and Atf3, in the absence of injury. Additionally, nociceptor deletion of Tsc2 activated satellite glial cells and macrophages in the dorsal root ganglia (DRG) in a similar manner to nerve injury. Surprisingly, these changes improved axon length but not percentage of initiating axons in dissociated cultures. The pro-regenerative environment in naïve DRG was recapitulated by AAV8-mediated deletion of Tsc2 in adult mice, suggesting that this phenotype does not result from a developmental effect. Consistently, AAV8-mediated Tsc2 deletion did not improve behavioral recovery after a sciatic nerve crush injury despite initially enhanced axon growth. Together, these data show that neuronal mTORC1 activation induces an incomplete pro-regenerative environment in the DRG that improves initial but not later axon growth after nerve injury.

Indexed as

AnimalsAxonsFemaleGanglia, SpinalGene ExpressionMaleMechanistic Target of Rapamycin Complex 1Mice, TransgenicNerve RegenerationNociceptorsSciatic NerveTuberous Sclerosis Complex 2 ProteinMechanistic Target of Rapamycin Complex 1Tsc2 protein, mouseTuberous Sclerosis Complex 2 Proteinaxon regenerationdorsal root ganglionmacrophagesmTORC1nociceptorTsc2

Identifiers

PMID31182472
PMCPMC6595439
OpenAlexW2949496506

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.